Change Healthcare Inc. (Nasdaq: CHNG) (the “Company” or “Change
Healthcare”), a leading independent healthcare technology company,
today reported financial results for the third quarter ended Dec.
31, 2020 of fiscal year 2021.
“Our third quarter results demonstrate the strength of the
Change Healthcare platform, and our ability to execute well on our
growth strategy and financial objectives while navigating the
pandemic,” said Neil de Crescenzo, president and chief executive
officer. “During the quarter we saw continued demand across our
platform. By advancing connectivity and driving innovation we have
established a strong foundation to accelerate the delivery of the
innovations and efficiencies essential to a brighter future for
health care.”
Fiscal 2021 Third Quarter Highlights:
Financial Summary
- Total revenue of $785.1 million, including solutions revenue of
$735.3 million
- Net income of $2.2 million, resulting in net income of $0.01
per diluted share
- Adjusted net income of $110.1 million, resulting in adjusted
net income of $0.34 per diluted share
- Adjusted EBITDA of $233.4 million
Recent Business Highlights
- Announced agreement with Carnegie Mellon University’s Delphi
Research Group for the launch of Delphi's enhanced COVIDcast
real-time COVID-19 indicators. COVIDcast is taking a further step
by adding de-identified COVID-19 claims from Change Healthcare to
its unique combination of survey, testing, and mobility data.
- Completed the divestiture of Capacity Management business. The
sale supported our strategy to focus on and invest in core aspects
of our business to fuel growth and advance innovation.
- Launched Social Determinants of Health (SDoH) Analytics, an
innovative national data resource to help health systems, insurers,
and life sciences organizations explore how geodemographic factors
affect patient outcomes.
- Subsequent to quarter-end, announced proposed merger with
OptumInsight, a diversified health services company and part of
UnitedHealth Group.
Impact of McKesson Exit on Comparability of Results
On March 10, 2020, Change Healthcare Inc. acquired the interest
in Change Healthcare LLC (“the Joint Venture”) previously held by
McKesson. The transaction resulted in Change Healthcare Inc.
acquiring control of the Joint Venture, which was accounted for as
a business combination and resulted in a new basis of accounting,
and all of the business activities of the Joint Venture are now
reported by the Company. Change Healthcare Inc. financial
statements for periods prior to the acquisition were primarily
limited to the equity method investment in the Joint Venture, and
therefore did not reflect revenue, adjusted EBITDA, and other key
measures. As a result, Change Healthcare does not consider
comparison of the current operating results to the reported results
of Change Healthcare Inc. for the same period in the prior year to
be meaningful, and instead will compare our current quarter results
to the prior quarter results of the Joint Venture, which have been
recast to reflect the current segment structure, including the
allocation of all corporate costs to the business units. This press
release includes supplemental information for the recast results of
the Joint Venture for the three and nine months ended December 31,
2019. The recast results for all quarters in fiscal year 2019 and
fiscal year 2020 are available in the appendix to the earnings
presentation and will be included as an exhibit to Change
Healthcare Inc.’s Form 10-Q.
Financial Results
- Solutions revenue was $735.3 million for the current period,
inclusive of the impact of the fair value adjustment to deferred
revenue resulting from the McKesson exit, which reduced revenue
recognized in the quarter by $24.2 million. Total revenue, which
includes postage revenue, was $785.1 million. For the third quarter
of fiscal 2020, the Joint Venture reported $752.5 million of
solutions revenue and $808.2 million of total revenue. Solutions
revenue for the current period reflects the $18.3 million net
favorable impact of acquisitions and divestitures including the
negative $2.2 million impact during the quarter from the
divestiture of the Capacity Management business which closed on
December 2, 2020. The quarter was also negatively impacted by the
COVID-19 pandemic, which was partially offset by new sales volumes
across all three segments.
- Net income was $2.2 million, resulting in net income of $0.01
per diluted share. For the third quarter of fiscal 2020, the Joint
Venture reported net income of $31.2 million or $0.10 per diluted
unit. Net income for the current period was positively impacted by
new sales volumes, productivity improvements and cost initiatives,
partially offset by the COVID-19 pandemic.
- Adjusted net income was $110.1 million, resulting in adjusted
net income of $0.34 per diluted share. For the third quarter of
fiscal 2020, the Joint Venture reported adjusted net income of
$106.3 million or $0.33 per diluted unit. Net income per diluted
share and adjusted net income per diluted share for the current
period is based on 325 million shares compared to 322 million units
in the prior year period.
- Adjusted EBITDA was $233.4 million for the current period. For
the third quarter of fiscal 2020, the Joint Venture reported
adjusted EBITDA of $232.6 million. The results in the current
quarter reflect continued productivity and synergy realization
which offset investments and COVID-19 revenue impacts.
Cash Flow and Balance Sheet Highlights
Net cash provided by operating activities was $487.2 million,
free cash flow was $304.3 million, and adjusted free cash flow was
$365.0 million, in each case, for the nine months ended December
31, 2020. For the nine months ended December 31, 2019, the Joint
Venture reported net cash provided by operating activities, free
cash flow, and adjusted free cash flow of $401.0 million, $213.8
million, and $324.9 million, respectively.
Net cash provided by operating activities, free cash flow, and
adjusted free cash flow each is affected by pass-thru funds we
receive from certain pharmaceutical industry participants in
advance of our obligation to remit these funds to participating
retail pharmacies. Such pass-thru funds on hand decreased by $10.1
million in the nine months ended December 31, 2020, reducing free
cash flow for the period by that amount, and increased by $1.8
million for the Joint Venture for the nine months ended December
31, 2019. The increase in cash flow from operations, free cash
flow, and adjusted free cash flow in the current period primarily
resulted from improved working capital driven by strong
collections.
The Company ended the quarter with approximately $137.4 million
of cash and cash equivalents, and approximately $4,817.8 million of
total debt. During the current period, the Company repaid $215.0
million on its Term Loan Facility.
Proposed Merger with OptumInsight
On January 5, 2021, OptumInsight (“Optum”), a diversified health
services company and part of UnitedHealth Group, and Change
Healthcare agreed to combine (the “Merger”). Under the terms of the
merger agreement, Optum, through a wholly-owned subsidiary, will
acquire all of the outstanding shares of Change Healthcare common
stock for $25.75 per share in cash. The Boards of Directors of both
UnitedHealth Group and Change Healthcare have unanimously approved
the terms of the Merger, and the Board of Directors of Change
Healthcare has recommended that Change Healthcare shareholders
adopt the merger agreement. The Merger is expected to be completed
in the second half of 2021 and is subject to applicable regulatory
approval and other customary closing conditions.
Guidance
Due to the recently proposed Merger, we will no longer be
providing financial guidance.
Webcast Information
Change Healthcare will host a conference call on Thursday,
February 4, 2021, at 8:00 a.m. ET. Due to the previously announced
transaction with OptumInsight, the Company will not be taking
questions during the conference call.
Investors and other interested parties are invited to listen to
the conference call via the Company's website at
https://ir.changehealthcare.com/. The webcast will be available for
on-demand listening at the aforementioned URL until February 4,
2022.
About Change Healthcare
Change Healthcare (Nasdaq: CHNG) is a leading independent
healthcare technology company, focused on insights, innovation, and
accelerating the transformation of the U.S. healthcare system
through the power of the Change Healthcare Platform. We provide
data and analytics-driven solutions to improve clinical, financial,
administrative, and patient engagement outcomes in the U.S.
healthcare system. Learn more at changehealthcare.com.
CHNG-IR
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995
with respect to the financial condition, results of operations and
businesses of Change Healthcare. Some of these statements can be
identified by terms and phrases such as “anticipate,” “believe,”
“intend,” “estimate,” “expect,” “continue,” “could,” “should,”
“may,” “plan,” “project,” “predict” and similar expressions. Change
Healthcare cautions readers of this press release that such
“forward looking statements,” including without limitation, those
relating to the timing of the proposed merger and Change
Healthcare’s future business prospects, revenue, working capital,
liquidity, capital needs, interest costs and income, wherever they
occur in this press release or in other statements attributable to
Change Healthcare, are necessarily estimates reflecting the
judgment of Change Healthcare’s senior management and involve a
number of risks and uncertainties that could cause actual results
to differ materially from those suggested by the “forward looking
statements.”
Factors that could cause Change Healthcare’s actual results to
differ materially from those expressed or implied in such
forward-looking statements include, but are not limited to, the
occurrence of any event, change or other circumstances that could
give rise to the termination of the merger agreement; the inability
to complete the proposed merger due to the failure to obtain
stockholder approval for the proposed merger or the failure to
satisfy other conditions to completion of the proposed merger,
including that a governmental entity may prohibit, delay or refuse
to grant approval for the consummation of the transaction; risks
related to disruption of management’s attention from Change
Healthcare’s ongoing business operations due to the transaction;
the effect of the announcement of the proposed merger on Change
Healthcare’s relationships with its customers, operating results
and business generally; the risk that the proposed merger will not
be consummated in a timely manner; exceeding the expected costs of
the merger; Change Healthcare’s ability to retain or renew existing
customers and attract new customers; macroeconomic and industry
trends and adverse developments in the debt, consumer credit and
financial services markets; uncertainty and risks related to the
impact of the COVID-19 pandemic on the national and global economy,
Change Healthcare’s business, suppliers, customers, and employees;
Change Healthcare’s ability to connect a large number of payers and
providers; Change Healthcare’s ability to provide competitive
services and prices while maintaining its margins; further
consolidation in end-customer markets; Change Healthcare’s ability
to effectively manage costs; Change Healthcare’s ability to
effectively develop and maintain relationships with channel
partners; a decline in transaction volume in the U.S. healthcare
industry; Change Healthcare’s ability to timely develop new
services and the market’s willingness to adopt new services; Change
Healthcare’s ability to maintain access to its data sources; Change
Healthcare’s ability to maintain the security and integrity of its
data; Change Healthcare’s ability to deliver services timely
without interruption; Change Healthcare’s ability to make
acquisitions and integrate the operations of acquired businesses;
government regulation and changes in the regulatory environment;
economic and political instability in the U.S. and international
markets where Change Healthcare operates; risks related to
international operations; the ability of outside service providers
and key vendors to fulfill their obligations to Change Healthcare;
litigation or regulatory proceedings; Change Healthcare’s ability
to protect and enforce its intellectual property, trade secrets and
other forms of unpatented intellectual property; Change
Healthcare’s ability to defend its intellectual property from
infringement claims by third parties; changes in local, state,
federal and international laws and regulations, including related
to taxation; Change Healthcare’s reliance on key management
personnel; Change Healthcare’s ability to manage and expand its
operations and keep up with rapidly changing technologies; our
adoption of new, or amendments to existing, accounting standards;
losses against which Change Healthcare does not insure; Change
Healthcare’s ability to make timely payments of principal and
interest on its indebtedness; Change Healthcare’s ability to
satisfy covenants in the agreements governing its indebtedness;
Change Healthcare’s ability to maintain liquidity, and other risks.
For a more detailed discussion of these factors, see the
information under the captions “Risk Factors” and “Management’s
Discussion and Analysis of Financial Condition and Results of
Operations” in Change Healthcare’s most recent Annual Report on
Form 10-K filed with the Securities and Exchange Commission (“SEC”)
on June 4, 2020, and in Change Healthcare’s most recent Quarterly
Report on Form 10-Q filed with the SEC on November 5, 2020.
Change Healthcare’s forward-looking statements speak only as of
the date of this press release or as of the date they are made.
Change Healthcare disclaims any intent or obligation to update any
“forward looking statement” made in this press release to reflect
changed assumptions, the occurrence of unanticipated events or
changes to future operating results over time.
Additional Information and Where to Find It
This press release may be deemed solicitation material in
respect of the proposed acquisition of Change Healthcare by
UnitedHealth Group. In connection with the proposed merger
transaction, Change Healthcare will file with the SEC and furnish
to Change Healthcare’s stockholders a proxy statement and other
relevant documents. This filing does not constitute a solicitation
of any vote or approval. Stockholders are urged to read the proxy
statement when it becomes available and any other documents to be
filed with the SEC in connection with the proposed merger or
incorporated by reference in the proxy statement because they will
contain important information about the proposed merger.
Investors will be able to obtain free of charge the proxy
statement and other documents filed with the SEC at the SEC’s
website at https://www.sec.gov. In addition, the proxy statement
and Change Healthcare’s annual reports on Form 10-K, quarterly
reports on Form 10-Q, current reports on Form 8-K and amendments to
those reports filed or furnished pursuant to section 13(a) or 15(d)
of the Securities Exchange Act of 1934 are available free of charge
through Change Healthcare’s website at
https://ir.changehealthcare.com. as soon as reasonably practicable
after they are electronically filed with, or furnished to, the
SEC.
The directors, executive officers and certain other members of
management and employees of Change Healthcare may be deemed
“participants” in the solicitation of proxies from stockholders of
Change Healthcare in favor of the proposed merger. Information
regarding the persons who may, under the rules of the SEC, be
considered participants in the solicitation of the stockholders of
Change Healthcare in connection with the proposed merger will be
set forth in the proxy statement and the other relevant documents
to be filed with the SEC. You can find information about the
Company’s executive officers and directors in its Annual Report on
Form 10-K for the fiscal year ended March 31, 2020 and in its
definitive proxy statement filed with the SEC on Schedule 14A on
July 16, 2020.
Non-GAAP Financial Measures
In the company’s earnings releases, prepared remarks, conference
calls, slide presentations and webcasts, there may be use or
discussion of non-GAAP financial measures. We believe such measures
provide supplemental information to investors with regards to our
operating performance and assist investors’ ability to compare our
financial results to those of other companies in the same industry.
The GAAP financial measure most directly comparable to each
non-GAAP financial measure used or discussed, and a reconciliation
of the differences between the comparable GAAP financial measure
and each non-GAAP financial measure are included in this press
release after the consolidated financial statements. These non-GAAP
financial measures are calculated and presented on the basis of
methodologies other than in accordance with GAAP. These non-GAAP
financial measures should be considered only as supplemental to,
and not as superior to, financial measures prepared in accordance
with GAAP and may be defined and calculated differently by others
in the same industry.
Consolidated Statements of
Operations
Quarter to Date
(unaudited and amounts in
thousands, except share and per share amounts)
Three Months Ended December
31,
2020
2019
2019
Change Healthcare Inc.
Change Healthcare LLC
Revenue:
Solutions revenue
$
735,264
$
—
$
752,533
Postage revenue
49,877
—
55,693
Total revenue
785,141
—
808,226
Operating expenses:
Cost of operations (exclusive of
depreciation and amortization below)
332,373
—
339,413
Research and development
58,323
—
50,618
Sales, marketing, general and
administrative
161,959
1,115
185,661
Customer postage
49,877
—
55,693
Depreciation and amortization
151,143
—
77,330
Accretion and changes in estimate with
related parties, net
956
(1,191
)
3,245
Gain on sale of businesses
(32,217
)
—
—
Total operating expenses
722,414
(76
)
711,960
Operating income (loss)
62,727
76
96,266
Non-operating (income) and
expense
Interest expense, net
61,439
1
66,353
Contingent consideration
—
—
900
Loss on extinguishment of debt
6,145
—
2,514
Loss from Equity Method Investment in the
Joint Venture
—
8,764
—
(Gain) loss on forward purchase
contract
—
(74,084
)
—
Other, net
(2,491
)
(580
)
(2,718
)
Total non-operating (income) and
expense
65,093
(65,899
)
67,049
Income (loss) before income tax
provision (benefit)
(2,366
)
65,975
29,217
Income tax provision (benefit)
(4,562
)
15,240
(1,974
)
Net income (loss)
$
2,196
$
50,735
$
31,191
Net income (loss) per common
share:
Basic
$
0.01
$
0.35
$
0.10
Diluted
$
0.01
$
0.35
$
0.10
Weighted average common shares
outstanding: (1)
Basic
321,013,595
143,392,295
319,387,487
Diluted (2)
324,815,524
146,201,860
322,197,051
(1)
Prior to the McKesson exit, common units
of Change Healthcare LLC were equivalent to the number of
outstanding common shares of Change Healthcare Inc. and membership
interests of Change Healthcare LLC held by subsidiaries of
McKesson.
(2)
Diluted shares outstanding includes the
dilutive impact of tangible equity units and equity compensation
arrangements.
Consolidated Statements of
Operations
Year to Date
(unaudited and amounts in
thousands, except share and per share amounts)
Nine Months Ended December
31,
2020
2019
2019
Change Healthcare Inc.
Change Healthcare LLC
Revenue:
Solutions revenue
$
2,089,589
$
—
$
2,288,305
Postage revenue
145,672
—
171,288
Total revenue
2,235,261
—
2,459,593
Operating expenses:
Cost of operations (exclusive of
depreciation and amortization below)
977,568
—
998,943
Research and development
168,110
—
151,778
Sales, marketing, general and
administrative
499,039
2,504
567,586
Customer postage
145,672
—
171,288
Depreciation and amortization
436,552
—
226,094
Accretion and changes in estimate with
related parties, net
10,414
47,172
10,339
Gain on sale of businesses
(60,487
)
—
—
Total operating expenses
2,176,868
49,676
2,126,028
Operating income (loss)
58,393
(49,676
)
333,565
Non-operating (income) and
expense
Interest expense, net
185,733
1
219,661
Contingent consideration
(3,000
)
—
1,809
Loss on extinguishment of debt
7,634
—
19,414
Loss from Equity Method Investment in the
Joint Venture
—
104,497
—
(Gain) loss on forward purchase
contract
—
(71,649
)
—
Other, net
(1,443
)
(1,245
)
(10,881
)
Total non-operating (income) and
expense
188,924
31,604
230,003
Income (loss) before income tax
provision (benefit)
(130,531
)
(81,280
)
103,562
Income tax provision (benefit)
(31,411
)
(564
)
589
Net income (loss)
$
(99,120
)
$
(80,716
)
$
102,973
Net income (loss) per common
share:
Basic
$
(0.31
)
$
(0.67
)
$
0.35
Diluted
$
(0.31
)
$
(0.67
)
$
0.34
Weighted average common shares
outstanding: (1)
Basic
320,570,092
120,657,859
296,653,051
Diluted
320,570,092
120,657,859
300,058,108
(1)
Prior to the McKesson exit, common units
of Change Healthcare LLC were equivalent to the number of
outstanding common shares of Change Healthcare Inc. and membership
interests of Change Healthcare LLC held by subsidiaries of
McKesson.
Consolidated Balance
Sheets
(unaudited and amounts in
thousands, except share and per share amounts)
December 31, 2020
March 31, 2020
Assets
Current assets:
Cash and cash equivalents
$
137,357
$
410,405
Accounts receivable, net
697,948
740,105
Contract assets, net
125,509
132,704
Prepaid expenses and other current
assets
127,442
117,967
Total current assets
1,088,256
1,401,181
Property and equipment, net
183,843
206,196
Operating lease right-of-use assets,
net
99,258
—
Goodwill
4,105,413
3,795,325
Intangible assets, net
4,302,594
4,365,806
Investment in business purchase option
—
146,500
Other noncurrent assets, net
368,448
192,372
Total assets
$
10,147,812
$
10,107,380
Liabilities
Current liabilities:
Accounts payable
$
59,664
$
68,169
Accrued expenses
502,992
390,294
Deferred revenue
393,823
302,313
Due to related parties, net
11,606
20,234
Current portion of long-term debt
37,019
278,779
Current portion of operating lease
liabilities
30,813
—
Total current liabilities
1,035,917
1,059,789
Long-term debt, excluding current
portion
4,780,828
4,710,294
Long-term operating lease liabilities
80,789
—
Deferred income tax liabilities
618,397
615,904
Tax receivable agreement obligations to
related parties
99,614
177,826
Tax receivable agreement obligations
228,294
164,633
Other long-term liabilities
70,235
93,487
Total liabilities
6,914,074
6,821,933
Commitments and contingencies
Stockholders' Equity
Common Stock (par value, $.001),
9,000,000,000 and 9,000,000,000 shares authorized and 304,656,863
and 303,428,142 shares issued and outstanding at December 31, 2020
and March 31, 2020, respectively
305
303
Preferred stock (par value, $.001),
900,000,000 and 900,000,000 shares authorized and no shares issued
and outstanding at December 31, 2020 and March 31, 2020,
respectively
—
—
Additional paid-in capital
4,253,567
4,222,580
Accumulated other comprehensive income
(loss)
9,467
(7,372
)
Accumulated deficit
(1,029,601
)
(930,064
)
Total stockholders' equity
3,233,738
3,285,447
Total liabilities and stockholders'
equity
$
10,147,812
$
10,107,380
Consolidated Statements of
Cash Flows
(unaudited and amounts in
thousands)
Nine Months Ended December
31,
2020
2019
2019
Change Healthcare Inc.
Change Healthcare LLC
Cash flows from operating
activities:
Net income (loss)
$
(99,120
)
$
(80,716
)
$
102,973
Adjustments to reconcile net income (loss)
to net cash provided by (used in) operating activities:
Loss from Equity Method Investment in the
Joint Venture
—
104,497
—
Depreciation and amortization
436,552
—
226,094
Amortization of capitalized software
developed for sale
550
—
10,456
Accretion and changes in estimate, net
8,429
—
10,339
Equity compensation
34,858
—
24,914
Deferred income tax expense (benefit)
(33,905
)
(564
)
(189
)
Amortization of debt discount and issuance
costs
24,587
403
14,406
Contingent consideration
(3,000
)
—
1,809
Gain on sale of businesses
(60,487
)
—
—
Loss on extinguishment of debt
7,634
—
19,414
(Gain) loss on forward purchase
contract
—
(71,649
)
—
Non-cash lease expense
21,930
—
—
Other, net
7,681
1,526
3,374
Changes in operating assets and
liabilities:
Accounts receivable, net
28,331
—
14,719
Contract assets, net
5,201
—
19,525
Prepaid expenses and other assets
(69,609
)
(1,335
)
(23,224
)
Accounts payable
(15,785
)
—
(32,031
)
Accrued expenses and other liabilities
68,708
47,255
13,994
Deferred revenue
124,679
—
(1,213
)
Due to the Joint Venture, net
—
583
—
Due to related party, net
—
—
(4,404
)
Net cash provided by (used in)
operating activities
487,234
—
400,956
Cash flows from investing
activities:
Capitalized expenditures
(182,929
)
—
(187,177
)
Acquisitions, net of cash acquired
(439,483
)
—
—
Proceeds from sale of businesses
117,124
—
—
Proceeds from sale of real estate
—
29,813
Investments in businesses
—
—
(19,010
)
Investment in the Joint Venture
—
(610,784
)
—
Investment in debt and equity securities
of the Joint Venture
—
(278,875
)
—
Other, net
1,100
7,332
—
Net cash provided by (used in)
investing activities
(504,188
)
(882,327
)
(176,374
)
Cash flows from financing
activities:
Payments on Revolving Facility
(250,000
)
—
—
Payments on Term Loan Facility
(265,000
)
—
(1,052,750
)
Proceeds from issuance of Senior Notes
325,000
—
—
Payments under tax receivable
agreements
(20,691
)
—
(27,227
)
Receipts (payments) on derivative
instruments
(22,255
)
—
2,403
Employee tax withholding on vesting of
equity compensation awards
(3,425
)
—
—
Payments on deferred financing
obligations
(9,081
)
—
(2,441
)
Payment of senior amortizing notes
(11,599
)
(7,332
)
—
Payment of debt issued to Change
Healthcare Inc.
—
—
(7,332
)
Proceeds from exercise of equity
awards
4,158
2,105
—
Capital contribution from Members from
exercise of equity compensation awards
—
—
2,338
Proceeds from initial public offering, net
of issuance costs
—
608,679
—
Proceeds from Change Healthcare Inc.
initial public offering
—
—
608,679
Proceeds from issuance of debt component
of tangible equity units
—
47,367
—
Proceeds from debt issued to Change
Healthcare Inc.
—
—
47,367
Proceeds from issuance of equity component
of tangible equity units, net of issuance costs
—
232,929
—
Proceeds from forward purchase contract
with Change Healthcare Inc.
—
—
232,929
Other, net
(6,650
)
(1,421
)
(3,471
)
Net cash provided by (used in)
financing activities
(259,543
)
882,327
(199,505
)
Effect of exchange rate changes on cash
and cash equivalents
3,449
—
526
Net increase (decrease) in cash and
cash equivalents
(273,048
)
—
25,603
Cash and cash equivalents at beginning of
period
410,405
3,409
48,894
Cash and cash equivalents at end of
period
$
137,357
$
3,409
$
74,497
Reconciliation of Net Income
(Loss) to Adjusted EBITDA
Quarter to Date
(unaudited and amounts in
thousands)
Three Months Ended December
31,
2020
2019
2019
Change Healthcare Inc.
(1)
Change Healthcare LLC
Net income (loss)
$
2,196
$
50,735
$
31,191
Income tax provision (benefit)
(4,562
)
15,240
(1,974
)
Income (loss) before income tax provision
(benefit)
(2,366
)
65,975
29,217
Amortization of capitalized software
developed for sale
460
3,755
Depreciation and amortization
151,143
77,330
Interest expense, net
61,439
66,353
Equity compensation
10,944
9,707
Acquisition accounting adjustments
20,601
440
Acquisition and divestiture-related
costs
2,661
1,481
Integration and related costs
9,688
21,470
Strategic initiatives, duplicative and
transition costs
4,324
4,645
Severance costs
2,591
4,191
Accretion and changes in estimate, net
(2,759
)
3,245
Management fees and related costs
—
2,648
Impairment of long-lived assets and
other
658
(435
)
Gain on sale of business
(32,217
)
—
Contingent consideration
—
900
Loss on extinguishment of debt
6,145
2,514
Other non-routine, net
112
5,166
Adjusted EBITDA
$
233,424
$
232,627
(1)
Prior to the McKesson exit, Change
Healthcare Inc. did not utilize adjusted EBITDA as a key
performance metric, therefore we have not presented a
reconciliation to adjusted EBITDA for the three months ended
December 31, 2019.
Reconciliation of Net Income
(Loss) to Adjusted EBITDA
Year to Date
(unaudited and amounts in
thousands)
Nine Months Ended December
31,
2020
2019
2019
Change Healthcare Inc.
(1)
Change Healthcare LLC
Net income (loss)
$
(99,120
)
$
(80,716
)
$
102,973
Income tax provision (benefit)
(31,411
)
(564
)
589
Income (loss) before income tax provision
(benefit)
(130,531
)
(81,280
)
103,562
Amortization of capitalized software
developed for sale
550
10,456
Depreciation and amortization
436,552
226,094
Interest expense, net
185,733
219,661
Equity compensation
34,858
24,914
Acquisition accounting adjustments
103,826
1,367
Acquisition and divestiture-related
costs
10,119
2,554
Integration and related costs
27,581
66,976
Strategic initiatives, duplicative and
transition costs
13,169
14,334
Severance costs
10,467
14,290
Accretion and changes in estimate, net
8,429
10,339
Management fees and related costs
—
7,708
Impairment of long-lived assets and
other
14,418
(1,275
)
Gain on sale of business
(60,487
)
—
Contingent consideration
(3,000
)
1,809
Loss on extinguishment of debt
7,634
19,414
Other non-routine, net
2,801
9,174
Adjusted EBITDA
$
662,119
$
731,377
(1)
Prior to the McKesson exit, Change
Healthcare Inc. did not utilize adjusted EBITDA as a key
performance metric, therefore we have not presented a
reconciliation to adjusted EBITDA for the nine months ended
December 31, 2019.
Reconciliation of Net Income
(Loss) to Adjusted Net Income (Loss)
(unaudited and amounts in
thousands, except share and per share amounts)
Three Months Ended December
31,
2020
2019
2019
Change Healthcare Inc.
(1)
Change Healthcare LLC
Net income (loss)
$
2,196
$
50,735
$
31,191
Amortization expense resulting from
acquisition method adjustments
117,075
34,922
EBITDA adjustments
22,748
55,972
Tax effect of EBITDA adjustments and
amortization expense
(31,945
)
(15,760
)
Adjusted net income (loss)
$
110,074
$
106,325
Adjusted net income (loss) per diluted
share (2)
$
0.34
$
0.33
Nine Months Ended December
31,
2020
2019
2019
Change Healthcare Inc.
(1)
Change Healthcare LLC
Net income (loss)
$
(99,120
)
$
(80,716
)
$
102,973
Amortization expense resulting from
acquisition method adjustments
345,972
104,624
EBITDA adjustments
169,815
171,604
Tax effect of EBITDA adjustments and
amortization expense
(121,911
)
(44,751
)
Adjusted net income (loss)
$
294,756
$
334,450
Adjusted net income (loss) per diluted
share (2)
$
0.92
$
1.11
(1)
Prior to the McKesson exit, Change
Healthcare Inc. did not utilize adjusted net income (loss) as a key
performance metric, therefore we have not presented a
reconciliation to adjusted net income (loss) for the three and nine
months ended December 31, 2019.
(2)
Prior to the McKesson exit, Common units
of Change Healthcare LLC were equivalent to the number of
outstanding common shares of Change Healthcare Inc. and membership
interests of Change Healthcare LLC held by subsidiaries of
McKesson.
Segment Results
(unaudited and amounts in
thousands)
Three Months Ended December
31,
2020
2019
2019
Change Healthcare Inc.
(1)
Change Healthcare LLC
(2)
Segment revenue
Software and Analytics
$
372,212
N/A
$
387,331
Network Solutions
192,588
N/A
150,697
Technology-Enabled Services
222,514
N/A
241,465
Postage and Eliminations (3)
22,006
N/A
28,733
Purchase Accounting Adjustment (4)
(24,179
)
N/A
—
Net revenue
$
785,141
N/A
$
808,226
Segment adjusted EBITDA
Software and Analytics
$
120,779
N/A
$
127,793
Network Solutions
103,847
N/A
87,571
Technology-Enabled Services
8,798
N/A
17,262
Postage and Eliminations
—
N/A
—
Total adjusted EBITDA
$
233,424
N/A
$
232,626
Nine Months Ended December
31,
2020
2019
2019
Change Healthcare Inc.
(1)
Change Healthcare LLC
(2)
Segment revenue
Software and Analytics
$
1,118,661
N/A
$
1,194,142
Network Solutions
519,509
N/A
436,585
Technology-Enabled Services
642,037
N/A
736,240
Postage and Eliminations (3)
73,142
N/A
92,626
Purchase Accounting Adjustment (4)
(118,088
)
N/A
—
Net revenue
$
2,235,261
N/A
$
2,459,593
Segment adjusted EBITDA
Software and Analytics
$
382,103
N/A
$
415,287
Network Solutions
268,858
N/A
246,319
Technology-Enabled Services
11,158
N/A
69,769
Postage and Eliminations
—
N/A
—
Total adjusted EBITDA
$
662,119
N/A
$
731,375
(1)
Prior to the McKesson exit, Change
Healthcare Inc. did not have revenues from customers and did not
utilize adjusted EBITDA as a key performance metric.
(2)
The prior year results of Change
Healthcare LLC have been retrospectively adjusted to be consistent
with the Company’s current segment structure and cost allocation
methodology.
(3)
Revenue for Postage and Eliminations
includes postage revenue of $49.9 million for Change Healthcare
Inc. for the three months ended December 31, 2020 and $55.7 million
for Change Healthcare LLC for the three months ended December 31,
2019. Revenue for Postage and Eliminations includes postage revenue
of $145.7 million for Change Healthcare Inc. for the nine months
ended December 31, 2020 and $171.3 million for Change Healthcare
LLC for the nine months ended December 31, 2019.
(4)
Amount reflects the impact to deferred
revenue resulting from the McKesson exit which reduced revenue
recognized during the three and nine months ended December 31,
2020.
Reconciliation of Cash
Provided by (Used in) Operating Activities to Free Cash Flow and
Adjusted Free Cash Flow
(unaudited and amounts in
thousands)
Nine Months Ended December
31,
2020
2019
2019
Change Healthcare Inc.
(1)
Change Healthcare LLC
Cash provided by (used in) operating
activities (2)
$
487,234
$
—
$
400,956
Capital expenditures
(182,929
)
—
(187,177
)
Free cash flow
304,305
—
213,779
Adjustments to free cash flow
(3):
Integration and related costs
27,581
66,976
Strategic initiatives, duplicative and
transition costs
13,169
14,334
Severance costs
10,467
14,290
Integration and strategic capital
expenditures
9,494
15,532
Adjusted free cash flow
$
365,016
$
324,911
(1)
Prior to the McKesson exit, Change
Healthcare Inc. did not utilize adjusted free cash flow as a key
performance metric, therefore we have not presented a
reconciliation to adjusted free cash flow for the nine months ended
December 31, 2019.
(2)
Includes cash used in pass-thru funds of
$10.1 million for Change Healthcare Inc. for the nine months ended
December 31, 2020 and cash provided by pass-thru funds of $1.8
million for Change Healthcare LLC for the nine months ended
December 31, 2019.
(3)
All operating costs and integration and
strategic capital expenditures are presented on an as-incurred
basis.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210203005152/en/
Evan Smith, CFA Investor Relations 404-338-2225
Evan.Smith@changehealthcare.com
Katherine Wojtecki External Communications 630-624-9142
Katherine.Wojtecki@changehealthcare.com
Change Healthcare (NASDAQ:CHNG)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Change Healthcare (NASDAQ:CHNG)
Historical Stock Chart
Von Jul 2023 bis Jul 2024